Companies / Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc.

Nasdaq: ARCTCIK 1768224SAN DIEGO, CA

Financials · FY2025

Revenue$82.03M
Net income$-65.78M
Total debt$15.00M
Cash$191.48M
Diluted EPS$-2.40
Shares outstanding28.4M

Ownership

28.4M shares outstanding · as of Aug 4, 2026
88.1%Institutions
Ownership
Institutions88.14%25,050,844
Public float11.86%3,372,225

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Barlow James FDirector
——
Farrell Peter CDirector
——
Holmes Edward WDirector
——
Mulroy DennisChief Financial Officer
——

Institutional holders 125

View all →
HolderValue% of shares
Federated Hermes Inc$25.50M11.62%
BlackRock, Inc.$17.57M9.20%
ARK Investment Management LLC$16.01M9.19%
Vanguard Group Inc$12.81M7.35%
Sumitomo Mitsui Trust Group, Inc.$12.42M7.13%
Amova Asset Management Americas, Inc.$12.40M7.13%
Two Sigma Investments, LP$8.35M3.81%
Geode Capital Management, LLC$5.10M2.33%
State Street Corporation$3.83M2.00%
Millennium Management LLC$3.69M1.68%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 1, 2026Mulroy Dennis
Executive
GrantEmployee Stock Option (right to buy)—+100K
100,000
0.35% of shares
low
Jun 5, 2026Holmes Edward W
Director
GrantStock option (right to buy)—+15K
15,000
0.05% of shares
low
Jun 5, 2026Barlow James F
Director
GrantStock option (right to buy)—+15K
15,000
0.05% of shares
low
Jun 5, 2026Farrell Peter C
Director
GrantStock option (right to buy)—+15K
15,000
0.05% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Federated Hermes IncPassive13G/A———
Balyasny Asset Management L.P.Passive13G/A—0—
ARK Investment Management LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ARCT——03969T109—